{"id":57155,"date":"2024-02-27T17:26:20","date_gmt":"2024-02-27T17:26:20","guid":{"rendered":"https:\/\/medsname.com\/amifru\/"},"modified":"2026-05-01T10:49:13","modified_gmt":"2026-05-01T10:49:13","slug":"amifru","status":"publish","type":"product","link":"https:\/\/medsbase.com\/ro\/product\/amifru\/","title":{"rendered":"Amifru"},"content":{"rendered":"<p><!-- medsbase-tldr-answer --><\/p>\n<div style=\"background:#fff8e1;border-left:4px solid #f5a623;padding:18px 22px;margin:0 0 24px 0;border-radius:4px;\">\n<h3 class=\"wp-block-heading\" style=\"margin:0 0 8px 0;font-size:16px;font-weight:700;\">\u26a1 R\u0103spuns rapid \u2014 Ce este Amifru?<\/h3>\n<p style=\"margin:0;\"><strong>Amifru<\/strong> este un <strong>Comprimat cu doz\u0103 fix\u0103 40\/5 mg<\/strong> de <strong>furosemid\u0103 (frusemid\u0103)<\/strong> \u2014 un diuretic de tip bucl\u0103 \u2014 \u0219i <strong>amilorid\u0103<\/strong> \u2014 un diuretic care economise\u0219te potasiu \u2014 de la Sun Pharma. Combina\u021bia este utilizat\u0103 atunci c\u00e2nd este necesar un diuretic de tip bucl\u0103, dar <strong>hipokaliemia este o problem\u0103<\/strong> \u2014 amilorida blocheaz\u0103 pierderea de potasiu la nivelul tubulului distal determinat\u0103 de activarea aldosteronului, echilibr\u00e2nd epuizarea potasiului cauzat\u0103 de \u00eenc\u0103rc\u0103tura de sodiu indus\u0103 de furosemid\u0103. Utiliz\u0103ri frecvente: hipertensiune arterial\u0103 cu edem, insuficien\u021b\u0103 cardiac\u0103 cronic\u0103 cu tendin\u021b\u0103 la hipokaliemie, ascit\u0103 hepatic\u0103 \u00een care spironolactona singur\u0103 nu asigur\u0103 o economisire adecvat\u0103 a potasiului. Dozaj tipic: un comprimat o dat\u0103 pe zi diminea\u021ba (unii pacien\u021bi necesit\u0103 de dou\u0103 ori pe zi). <strong>Contraindica\u021bii absolute \u00een anurie, hiperkaliemie &gt;5,5, BCR sever\u0103 (TFG &lt;30) \u0219i boala Addison<\/strong>. Monitora\u021bi nivelul de potasiu, sodiu \u0219i creatinin\u0103 la ini\u021bierea tratamentului \u0219i apoi \u00een mod regulat.<\/p>\n<\/div>\n<div class=\"medsbase-trust-strip\" style=\"background:#f4f8fb;border:1px solid #d8e3eb;padding:12px 16px;margin:16px 0;border-radius:4px;font-size:14px;\">\n<strong>Ce beneficii ofer\u0103 MedsBase:<\/strong> Produc\u0103tor certificat WHO-GMP \u00b7 Ambalaj discret \u00b7 Livrare la nivel mondial \u00b7 Peste 1.400 de recenzii verificate <a href=\"https:\/\/medsbase.com\/ro\/reviews\/\">ale clien\u021bilor<\/a>\n<\/div>\n<p class=\"medsbase-reship-line\" style=\"font-size:14px;color:#444;margin:8px 0 18px;\">\ud83d\udce6 Fiecare comand\u0103 este acoperit\u0103 de politica noastr\u0103 de <a href=\"https:\/\/medsbase.com\/ro\/medsbase-re-shipment-assurance-policy\/\"><strong>Politica noastr\u0103 de Reexpediere Garantat\u0103<\/strong><\/a> \u2014 dac\u0103 coletul dumneavoastr\u0103 nu sose\u0219te \u00een 20 de zile lucr\u0103toare, \u00eel relivr\u0103m.<\/p>\n<h3>De ce s\u0103 comanzi de la MedsBase<\/h3>\n<p>Medicamentele noastre generice sunt procurate de la produc\u0103tori certifica\u021bi WHO-GMP \u0219i expediate la nivel mondial \u00een ambalaje discrete \u0219i simple \u2014 f\u0103r\u0103 denumirea medicamentului pe exteriorul coletului. Pl\u0103\u021bile cu cardul sunt procesate printr-un procesor reglementat (descrierile de pe extrasul de cont includ un procesor de pl\u0103\u021bi cu card reglementat \u2014 niciodat\u0103 \u201cMedsBase\u201d sau numele vreunui medicament). Accept\u0103m \u0219i criptomonede \u0219i transferuri bancare SEPA. Fiecare comand\u0103 este sus\u021binut\u0103 de Politica noastr\u0103 de Asigurare pentru Relivrare.<\/p>\n<h2 class=\"wp-block-heading\">Ce este Amifru?<\/h2>\n<p>Amifru este un comprimat cu doz\u0103 fix\u0103 combinat\u0103 pentru administrare oral\u0103, care con\u021bine <strong>furosemid\u0103 (frusemid\u0103)<\/strong> \u0219i <strong>amilorid\u0103<\/strong> \u00eentr-o singur\u0103 pastil\u0103 (raport tipic 40 mg furosemid\u0103 + 5 mg amilorid\u0103 pe comprimat). Produs de Sun Pharma, disponibil \u00een cutii de 30-180 de comprimate.<\/p>\n<p>Furosemida este diureticul de referin\u021b\u0103 din clasa diureticelor de ans\u0103, introdus\u0103 \u00een 1964 sub denumirea Lasix. Amilorida este un diuretic care economise\u0219te potasiu, ac\u021bion\u00e2nd la nivelul canalului de sodiu epithelial (ENaC) \u00een tubulul distal \u2014 introdus\u0103 de MSD \u00een 1967 special pentru a compensa pierderea de potasiu cauzat\u0103 de diureticele de ans\u0103 \u0219i tiazidice.<\/p>\n<h2 class=\"wp-block-heading\">De ce se combin\u0103 Furosemida cu Amilorida?<\/h2>\n<p>Diureticele de ans\u0103 determin\u0103 livrarea unor cantit\u0103\u021bi mari de sodiu la nivelul tubulului distal. Aldosteronul stimuleaz\u0103 apoi reabsorb\u021bia distal\u0103 de sodiu \u00een schimbul excre\u021biei de potasiu \u2014 mecanismul clasic al hipokaliemiei induse de diureticele de ans\u0103. Exist\u0103 dou\u0103 strategii contrare:<\/p>\n<ul>\n<li><strong>Blocarea receptorului de mineralocorticoizi<\/strong> (spironolacton\u0103, eplerenon\u0103) \u2014 previne semnalizarea aldosteronului.<\/li>\n<li><strong>Blocarea direct\u0103 a canalului de sodiu epithelial<\/strong> (amilorid\u0103, triamteren\u0103) \u2014 ac\u021bioneaz\u0103 \u00een aval de aldosteron, deci este eficient indiferent dac\u0103 nivelul aldosteronului este crescut sau nu.<\/li>\n<\/ul>\n<p>Amilorida este preferat\u0103 \u00een locul spironolactonei \u00een urm\u0103toarele situa\u021bii:<\/p>\n<ul>\n<li>Pacientul a dezvoltat ginecomastie sau mastalgie sub tratament cu spironolacton\u0103<\/li>\n<li>Eplerenona (antagonist selectiv al receptorilor de mineralocorticoizi) nu este disponibil\u0103 sau este prea costisitoare<\/li>\n<li>Este necesar un efect rapid de economisire a potasiului \u2014 amilorida ac\u021bioneaz\u0103 \u00een c\u00e2teva ore, \u00een timp ce spironolactona necesit\u0103 24-72 de ore<\/li>\n<li>Pacientul nu tolereaz\u0103 efectele anti-androgene ale spironolactonei<\/li>\n<\/ul>\n<p>Amifru este deosebit de util \u00een <strong>ascit\u0103 hepatic\u0103<\/strong> (unde pierderile de potasiu sunt adesea severe), <strong>pacien\u021bi cu IC cronic\u0103 \u0219i potasiu instabil<\/strong>, \u0219i <strong>pacien\u021bii care au nevoie de un efect rapid de diuretic de ans\u0103 f\u0103r\u0103 sc\u0103derea potasiului<\/strong>.<\/p>\n<h2 class=\"wp-block-heading\">Doza \u0219i titrare<\/h2>\n<p><strong>Doza standard:<\/strong> o tablet\u0103 de 40\/5 mg o dat\u0103 pe zi diminea\u021ba.<\/p>\n<p><strong>Titrarea:<\/strong> <\/p>\n<ul>\n<li>Insuficien\u021b\u0103 cardiac\u0103 sau edem necontrolat cu o tablet\u0103: cre\u0219te\u021bi la dou\u0103 tablete pe zi sau ad\u0103uga\u021bi o administrare diminea\u021b\u0103 + dup\u0103-amiaz\u0103 (evita\u021bi dozele seara \u2014 nocturie).<\/li>\n<li>Ascit\u0103 cirotic\u0103: adesea combinat\u0103 cu spironolacton\u0103 100-200 mg pentru acoperire complet\u0103 de antagonist al aldosteronului.<\/li>\n<li>Hipertensiune: doza\u021bi ca mai sus; majoritatea pacien\u021bilor hipertensivi nu au nevoie de combina\u021bii cu diuretice de ans\u0103 \u2014 dac\u0103 TA r\u0103m\u00e2ne necontrolat\u0103 pe un triple ACEi\/ARB + CCB + tiazidic\u0103, trece\u021bi la spironolacton\u0103 (PATHWAY-2) \u00een loc s\u0103 trece\u021bi la o combina\u021bie cu diuretic de ans\u0103, cu excep\u021bia cazurilor \u00een care func\u021bia renal\u0103 face tiazidicele ineficiente.<\/li>\n<\/ul>\n<p><strong>Program de monitorizare:<\/strong><\/p>\n<ul>\n<li><strong>Valori ini\u021biale:<\/strong> uree, potasiu, sodiu, creatinin\u0103, eGFR. TA, greutate zilnic\u0103 (dac\u0103 IC), urat seric, glucoz\u0103.<\/li>\n<li><strong>la 1-2 s\u0103pt\u0103m\u00e2ni dup\u0103 \u00eenceperea sau modificarea dozei:<\/strong> repetare U&amp;E. Monitorizare at\u00e2t pentru hipokaliemie (dac\u0103 doza de amilorid\u0103 este insuficient\u0103) c\u00e2t \u0219i pentru hiperkaliemie (dac\u0103 terapia tripl\u0103 amilorid\u0103\/ACEi\/ARB este activ\u0103).<\/li>\n<li><strong>4-6 s\u0103pt\u0103m\u00e2ni:<\/strong> control TA; repetare panel complet.<\/li>\n<li><strong>Continuu:<\/strong> la fiecare 3-6 luni, sau mai frecvent \u00een IRC sau IC instabil\u0103.<\/li>\n<li><strong>Opri\u021bi \u0219i investiga\u021bi:<\/strong> potasiu 5,5, sodiu 30%, acces de gut\u0103, ame\u021beli persistente sau simptome posturale.<\/li>\n<\/ul>\n<h2 class=\"wp-block-heading\">Efecte Secundare<\/h2>\n<p><strong>Frecvente (&gt;1%):<\/strong><\/p>\n<ul>\n<li>Cre\u0219tere a diurezei, \u00een special \u00een primele 1-2 ore dup\u0103 administrare<\/li>\n<li>Ame\u021beli posturale (supradiurez\u0103)<\/li>\n<li>Modific\u0103ri electrolitice \u2014 hiponatremie, hipomagnezemie. Potasiul de obicei stabil dar hiperkaliemie posibil\u0103 dac\u0103 doza de amilorid\u0103 este dispropor\u021bionat mare sau \u00een combina\u021bie cu ACEi\/ARB.<\/li>\n<li>Hiperuricemie \u0219i acces de gut\u0103<\/li>\n<li>Hiperglicemie u\u0219oar\u0103<\/li>\n<li>Erup\u021bie cutanat\u0103 (hipersensibilitate la sulfonamide poate afecta ambele componente)<\/li>\n<li>Oboseal\u0103, crampe musculare<\/li>\n<\/ul>\n<p><strong>Pu\u021bin frecvente, dar clinic importante:<\/strong><\/p>\n<ul>\n<li><strong>Hiperkaliemie sever\u0103<\/strong> \u2014 riscul principal c\u00e2nd amilorida este combinat\u0103 cu ACEi, ARB, suplimente de potasiu, sau \u00een IRC<\/li>\n<li><strong>Hiponatremie sever\u0103<\/strong> \u2014 mai frecvent la femeile \u00een v\u00e2rst\u0103 cu diete s\u0103race \u00een sare<\/li>\n<li><strong>Leziune renal\u0103 acut\u0103<\/strong> \u2014 \u00een special cu terapia concomitent\u0103 NSAID + ACEi\/ARB (\u201ctriplu impact\u201d)<\/li>\n<li><strong>Ototoxicitate<\/strong> cu furosemid\u0103 IV \u00een doze mari (nu este o problem\u0103 la dozele orale standard)<\/li>\n<li><strong>Pancreatit\u0103<\/strong> (efect rar de clas\u0103 loop\/tiazidic\u0103)<\/li>\n<li><strong>Icter colestatic<\/strong> (rar)<\/li>\n<\/ul>\n<h2 class=\"wp-block-heading\">Contraindica\u021bii<\/h2>\n<ul>\n<li><strong>Hiperkaliemie &gt;5,5 mmol\/L la evaluarea ini\u021bial\u0103<\/strong> \u2014 amilorida va agrava<\/li>\n<li><strong>Insuficien\u021b\u0103 renal\u0103 sever\u0103 (TFG &lt;30)<\/strong><\/li>\n<li><strong>Anurie<\/strong><\/li>\n<li><strong>Boala Addison<\/strong> (insuficien\u021b\u0103 adrenal\u0103 primar\u0103) \u2014 risc de hiperkaliemie<\/li>\n<li><strong>Suplimente de potasiu concomitente<\/strong> (dec\u00e2t dac\u0103 se monitorizeaz\u0103 atent)<\/li>\n<li><strong>Diuretic potasiu-sparator concomitent<\/strong> (spironolacton\u0103, eplerenon\u0103, triamteren\u0103) \u2014 hiperkaliemie aditiv\u0103<\/li>\n<li><strong>Hipersensibilitate la sulfonamide<\/strong> (pentru componenta furosemid\u0103)<\/li>\n<li><strong>Insuficien\u021b\u0103 hepatic\u0103 sever\u0103 cu encefalopatie hepatic\u0103<\/strong> \u2014 risc de precipita\u021bie a comei prin schimbarea electroli\u021bilor<\/li>\n<li><strong>Deshidratare sever\u0103 \u0219i azotemie prerenal\u0103<\/strong><\/li>\n<li><strong>Hiponatremie simptomatic\u0103 (Na &lt;130)<\/strong> la evaluarea ini\u021bial\u0103<\/li>\n<\/ul>\n<p><strong>Sarcina:<\/strong> \u00een general evitate. Diureticele de ans\u0103 trec placenta; datele privind amilorida \u00een sarcin\u0103 sunt limitate. Utiliza\u021bi doar pentru indica\u021bii imperative (edem pulmonar) sub \u00eengrijire specializat\u0103.<\/p>\n<h2 class=\"wp-block-heading\">Interac\u021biuni medicamentoase<\/h2>\n<ul>\n<li><strong>Inhibitori ACE, ARB, aliskiren<\/strong> \u2014 <strong>hiperkaliemie aditiv\u0103<\/strong>. Combina\u021bia este uneori necesar\u0103 \u00een IC, dar necesit\u0103 monitorizare atent\u0103 (K+ la 1 s\u0103pt\u0103m\u00e2n\u0103, 1 lun\u0103, apoi la fiecare 3 luni). Evita\u021bi la eGFR &lt;45.<\/li>\n<li><strong>Suplimente de potasiu, \u00eenlocuitori de sare, alte diuretice economisoare de potasiu<\/strong> \u2014 risc de hiperkaliemie. \u00cen general nu combina\u021bi.<\/li>\n<li><strong>Litiu \u2014 CRITIC.<\/strong> Componenta furosemid\u0103 reduce clearance-ul de litiu; monitoriza\u021bi nivelurile s\u0103pt\u0103m\u00e2nal \u00een prima lun\u0103 dac\u0103 combina\u021bia este inevitabil\u0103 \u0219i reduce\u021bi doza de litiu cu 25-50%.<\/li>\n<li><strong>AINS<\/strong> \u2014 reduc efectul diuretic; cresc substan\u021bial riscul de ARI atunci c\u00e2nd sunt combinate cu ACEi\/ARB (triplu impact).<\/li>\n<li><strong>Digoxin\u0103<\/strong> \u2014 verifica\u021bi str\u00e2ns potasiul; hipokaliemia precipiteaz\u0103 toxicitatea digoxin\u0103; monitoriza\u021bi nivelurile de digoxin.<\/li>\n<li><strong>Antibiotice aminoglicozidice (gentamicin\u0103, amikacin\u0103)<\/strong> \u2014 ototoxicitate aditiv\u0103 cu furosemida la doze IV mari.<\/li>\n<li><strong>Corticoesteroizi, amfotericin\u0103 B<\/strong> \u2014 tulburare electrolitic\u0103 aditiv\u0103.<\/li>\n<li><strong>Colestiramin\u0103 \/ colestipol<\/strong> \u2014 reduc absorb\u021bia furosemidei cu 50%. Separa\u021bi administrarea cu 4 ore.<\/li>\n<li><strong>Alcool<\/strong> \u2014 hipotensiune postural\u0103 aditiv\u0103.<\/li>\n<\/ul>\n<h2 class=\"wp-block-heading\">Depozitare<\/h2>\n<p>P\u0103stra\u021bi Amifru sub 25\u00b0C \u00een blisterul original. Depozita\u021bi \u00een afara accesului copiilor.<\/p>\n<h2 id=\"faqs\">\u00centreb\u0103ri frecvente<\/h2>\n<h3 class=\"wp-block-heading\">De ce a\u0219 alege Amifru \u00een loc de furosemid\u0103 simpl\u0103?<\/h3>\n<p>Trei situa\u021bii. \u00cen primul r\u00e2nd, dac\u0103 a\u021bi dezvoltat hipokaliemie la administrarea de furosemid\u0103 singur\u0103 \u0219i dori\u021bi un <strong>component \u00eencorporat care s\u0103 economiseasc\u0103 potasiu<\/strong> f\u0103r\u0103 a ad\u0103uga un comprimat separat de spironolacton\u0103. \u00cen al doilea r\u00e2nd, dac\u0103 a\u021bi dezvoltat ginecomastie sau durere mamilar\u0103 la administrarea de spironolacton\u0103 \u0219i ave\u021bi nevoie de o alternativ\u0103 non-steroidal\u0103. \u00cen al treilea r\u00e2nd, dac\u0103 <strong>efectul rapid de economisire a potasiului<\/strong> este necesar \u2014 amilorida ac\u021bioneaz\u0103 \u00een c\u00e2teva ore, \u00een timp ce spironolactona necesit\u0103 24-72 de ore prin intermediul metaboli\u021bilor s\u0103i activi.<\/p>\n<h3 class=\"wp-block-heading\">C\u00e2nd ar trebui s\u0103 iau Amifru?<\/h3>\n<p>Diminea\u021ba, cu sau f\u0103r\u0103 m\u00e2ncare. Efectul diuretic atinge maximul la 1-2 ore dup\u0103 administrare \u0219i se estompeaz\u0103 \u00een mare parte p\u00e2n\u0103 seara. Administrarea seara provoac\u0103 nicturie \u0219i perturb\u0103 somnul.<\/p>\n<h3 class=\"wp-block-heading\">Pot lua Amifru cu un inhibitor ACE sau ARB?<\/h3>\n<p>Da, cu monitorizare. Combina\u021bia de amilorid\u0103 + inhibitor ACE (sau + ARB) cre\u0219te semnificativ nivelul de potasiu \u0219i ar trebui evitat\u0103 \u00een cazul BCR avansat (eGFR 5,0. Dac\u0103 se combin\u0103, verifica\u021bi potasiul la 1 s\u0103pt\u0103m\u00e2n\u0103, 1 lun\u0103 \u0219i la fiecare 3 luni. Mul\u021bi pacien\u021bi \u00een aceast\u0103 situa\u021bie se descurc\u0103 mai bine cu un diuretic de ans\u0103 singur + inhibitor ACE\/ARB (f\u0103r\u0103 amilorid\u0103), accept\u00e2nd un supliment de potasiu dac\u0103 este necesar.<\/p>\n<h3 class=\"wp-block-heading\">Este Amifru un medicament de prim\u0103 linie pentru tensiunea arterial\u0103?<\/h3>\n<p>Nu. Combina\u021biile de diuretice de ans\u0103 sunt rezervate pentru indica\u021bii specifice \u2014 hipertensiune cu edem sau BCR avansat, insuficien\u021b\u0103 cardiac\u0103 cronic\u0103 sau ascit\u0103 cirotic\u0103. Pentru hipertensiunea standard, \u00eencepe\u021bi cu un ARB sau inhibitor ACE, ad\u0103uga\u021bi un blocant al canalelor de calciu sau un tiazidic \u0219i trece\u021bi la spironolacton\u0103 (studiul PATHWAY-2) \u00eenainte de o combina\u021bie de diuretic de ans\u0103.<\/p>\n<h3 class=\"wp-block-heading\">Voi pierde sau voi c\u00e2\u0219tiga potasiu cu Amifru?<\/h3>\n<p>Combina\u021bia este conceput\u0103 s\u0103 fie <strong>neutr\u0103 din punct de vedere al potasiului<\/strong> \u2014 furosemide reduce nivelul de potasiu, amilorid \u00eel men\u021bine, iar efectul net este de obicei un potasiu stabil. Un num\u0103r mic de pacien\u021bi pot avea varia\u021bii \u00een func\u021bie de diet\u0103, func\u021bia renal\u0103 \u0219i medicamentele concomitente (ACEi\/ARB cresc potasiul; corticosteroidele \u00eel scad). Verifica\u021bi potasiul la \u00eenceput \u0219i dup\u0103 1-2 s\u0103pt\u0103m\u00e2ni pentru a vedea \u00een ce direc\u021bie evolueaz\u0103.<\/p>\n<h3 class=\"wp-block-heading\">Am gut\u0103 \u2014 pot lua Amifru?<\/h3>\n<p>Cu precau\u021bie. Componenta furosemid\u0103 poate cre\u0219te acidul uric seric \u0219i poate declan\u0219a accese de gut\u0103. Dac\u0103 gut\u0103 este activ\u0103, trata\u021bi gut\u0103 cu terapie de reducere a uratului (alopurinol) \u00een loc s\u0103 \u00eentrerupe\u021bi Amifru \u2014 indica\u021bia de baz\u0103 (IC, edem, BCR avansat\u0103) de obicei nu poate fi gestionat\u0103 f\u0103r\u0103 un diuretic de ans\u0103.<\/p>\n<h3 class=\"wp-block-heading\">Pot lua ibuprofen cu Amifru?<\/h3>\n<p>Utilizarea cronic\u0103 a AINS-urilor este riscant\u0103 \u00een combina\u021bie cu orice diuretic de ans\u0103 \u2014 reduc efectul diuretic \u0219i cresc semnificativ riscul de leziune renal\u0103 acut\u0103 atunci c\u00e2nd sunt combinate cu un inhibitor ACE sau ARB. Prefera\u021bi paracetamolul pentru dureri cronice.<\/p>\n<h3 class=\"wp-block-heading\">Ce fac dac\u0103 uit o doz\u0103?<\/h3>\n<p>Lua\u021bi-l c\u00e2nd v\u0103 aminti\u021bi, cu excep\u021bia cazului \u00een care este aproape timpul pentru urm\u0103toarea doz\u0103 \u2014 \u00een acest caz, omite\u021bi doza uitat\u0103. Nu dubla\u021bi doza. O singur\u0103 doz\u0103 omis\u0103 \u00een IC cronic\u0103 poate permite acumularea de lichide; monitoriza\u021bi greutatea \u00een ziua urm\u0103toare.<\/p>\n<h3 class=\"wp-block-heading\">Pot lua Amifru \u00een sarcin\u0103?<\/h3>\n<p>Evitat \u00een mod obi\u0219nuit. Diureticele de ans\u0103 trec placenta \u0219i datele despre amilorid \u00een sarcin\u0103 sunt limitate. Folosi\u021bi doar pentru indica\u021bii imperioase (edem pulmonar, insuficien\u021b\u0103 cardiac\u0103 rezistent\u0103) sub \u00eendrumare specializat\u0103.<\/p>\n<h3 class=\"wp-block-heading\">Unde pot cump\u0103ra Amifru online?<\/h3>\n<p>Pute\u021bi cump\u0103ra Amifru (40\/5 mg furosemid\u0103 + amilorid, 30-180 comprimate) de la MedsBase cu ambalaj discret \u0219i livrare \u00een \u00eentreaga lume.<\/p>\n<h2 class=\"wp-block-heading\">Antihipertensive \u0219i Diuretice Asem\u0103n\u0103toare pe MedsBase<\/h2>\n<ul>\n<li><a href=\"https:\/\/medsbase.com\/ro\/aldactone\/\">Aldactone \u2014 Spironolacton\u0103 25 mg (antagonist al aldosteronului)<\/a><\/li>\n<li><a href=\"https:\/\/medsbase.com\/ro\/amlode\/\">Amlode \u2014 Amlodipin\u0103 5\/10 mg (CCB)<\/a><\/li>\n<li><a href=\"https:\/\/medsbase.com\/ro\/aquazide\/\">Aquazide \u2014 Hidroclorotiazid\u0103 (HCTZ) tiazidic\u0103<\/a><\/li>\n<li><a href=\"https:\/\/medsbase.com\/ro\/hyros\/\">Hyros \u2014 Hidroclorotiazid\u0103 (HCTZ)<\/a><\/li>\n<li><a href=\"https:\/\/medsbase.com\/ro\/losar\/\">Losar \u2014 Losartan (ARB asociat cu diuretic)<\/a><\/li>\n<li><a href=\"https:\/\/medsbase.com\/ro\/ramcor\/\">Ramcor \u2014 Ramipril (partener ACEi pentru diuretic)<\/a><\/li>\n<li><a href=\"https:\/\/medsbase.com\/ro\/high-blood-pressure-medication\/\"><strong>R\u0103sfoi\u021bi toate medicamentele pentru hipertensiune arterial\u0103<\/strong><\/a><\/li>\n<\/ul>\n<div style=\"background:#fff3f3;border-left:4px solid #d9534f;padding:16px 20px;margin:24px 0;border-radius:4px;\"><strong>\u2695 Dezaprobare medical\u0103.<\/strong> Aceast\u0103 pagin\u0103 are scop informativ \u0219i nu \u00eenlocuie\u0219te sfatul medical al unui medic calificat. Hipertensiunea, insuficien\u021ba cardiac\u0103 \u0219i aritmiile necesit\u0103 diagnostic, monitorizare \u0219i individualizarea dozei de c\u0103tre un medic \u2014 utiliza\u021bi \u00eentotdeauna beta-blocante sub \u00eendrumare medical\u0103.<\/div>\n<p><!-- medsbase-related-alts-v1 --><\/p>\n<h3 class=\"wp-block-heading\">Alternative conexe<\/h3>\n<p>Alte produse din <strong>Afec\u021biuni cronice<\/strong> pe care clien\u021bii le vizualizeaz\u0103 de asemenea:<\/p>\n<ul>\n<li><a href=\"https:\/\/medsbase.com\/ro\/allegra\/\">Allegra<\/a><\/li>\n<li><a href=\"https:\/\/medsbase.com\/ro\/ritocom\/\">Ritocom<\/a><\/li>\n<li><a href=\"https:\/\/medsbase.com\/ro\/telmaheal\/\">Telmaheal<\/a><\/li>\n<li><a href=\"https:\/\/medsbase.com\/ro\/lox-10-spray\/\">Spray Lox 10%<\/a><\/li>\n<li><a href=\"https:\/\/medsbase.com\/ro\/predniheal\/\">Predniheal<\/a><\/li>\n<\/ul>","protected":false},"excerpt":{"rendered":"<p>Amifru este comprimatul cu doz\u0103 fix\u0103 de furosemid\u0103 40 mg + amilorid\u0103 5 mg de la Sun Pharma \u2014 combin\u0103 un diuretic de tip bucl\u0103 cu un agent care economise\u0219te potasiu, ac\u021bion\u00e2nd pe ENaC. Conceput pentru a preveni hipokaliemia indus\u0103 de diureticele de tip bucl\u0103 f\u0103r\u0103 a ad\u0103uga spironolacton\u0103. Preferat atunci c\u00e2nd ginecomastia contraindic\u0103 spironolactona sau c\u00e2nd este necesar un efect rapid de economisire a potasiului (ore, nu zile). Utiliz\u0103ri: insuficien\u021b\u0103 cardiac\u0103 cu potasiu instabil, ascit\u0103 hepatic\u0103, edem la pacien\u021bii cu BCR.<\/p>","protected":false},"featured_media":57156,"comment_status":"open","ping_status":"open","template":"","meta":[],"product_brand":[],"product_cat":[3141,3223,3260,3356],"product_tag":[4244,4245,4239],"class_list":{"0":"post-57155","1":"product","2":"type-product","3":"status-publish","4":"has-post-thumbnail","6":"product_cat-category-overview","7":"product_cat-chronic-conditions","8":"product_cat-heart-blood-pressure","9":"product_cat-high-blood-pressure-medication","10":"product_tag-amifru","11":"product_tag-amiloride","12":"product_tag-frusemide","14":"first","15":"instock","16":"shipping-taxable","17":"purchasable","18":"product-type-variable","19":"has-default-attributes"},"acf":[],"_links":{"self":[{"href":"https:\/\/medsbase.com\/ro\/wp-json\/wp\/v2\/product\/57155","targetHints":{"allow":["GET"]}}],"collection":[{"href":"https:\/\/medsbase.com\/ro\/wp-json\/wp\/v2\/product"}],"about":[{"href":"https:\/\/medsbase.com\/ro\/wp-json\/wp\/v2\/types\/product"}],"replies":[{"embeddable":true,"href":"https:\/\/medsbase.com\/ro\/wp-json\/wp\/v2\/comments?post=57155"}],"wp:featuredmedia":[{"embeddable":true,"href":"https:\/\/medsbase.com\/ro\/wp-json\/wp\/v2\/media\/57156"}],"wp:attachment":[{"href":"https:\/\/medsbase.com\/ro\/wp-json\/wp\/v2\/media?parent=57155"}],"wp:term":[{"taxonomy":"product_brand","embeddable":true,"href":"https:\/\/medsbase.com\/ro\/wp-json\/wp\/v2\/product_brand?post=57155"},{"taxonomy":"product_cat","embeddable":true,"href":"https:\/\/medsbase.com\/ro\/wp-json\/wp\/v2\/product_cat?post=57155"},{"taxonomy":"product_tag","embeddable":true,"href":"https:\/\/medsbase.com\/ro\/wp-json\/wp\/v2\/product_tag?post=57155"}],"curies":[{"name":"wp","href":"https:\/\/api.w.org\/{rel}","templated":true}]}}